T 0601/05 (Anti-TNF alpha human monoclonal antibodies/BAYER I) of 18.10.2007
- European Case Law Identifier
- ECLI:EP:BA:2007:T060105.20071018
- Date of decision
- 18 October 2007
- Case number
- T 0601/05
- Petition for review of
- -
- Application number
- 94102560.3
- IPC class
- C07K 16/24
- Language of proceedings
- English
- Distribution
- Distributed to board chairmen (C)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- T 0601/05 Anti-TNF alpha human monoclonal antibodies/BAYER II 2008-04-24T 0601/05 Anti-TNF alpha human monoclonal antibodies/BAYER III 2009-12-02
- Abstracts for this decision
- -
- Application title
- Anti-TNF alpha human monoclonal antibodies
- Applicant name
- Bayer Corporation
- Opponent name
- Centocor, Inc.
Abbott Laboratories - Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 108 1973European Patent Convention Art 123(2) 1973European Patent Convention Art 123(3) 1973European Patent Convention Art 54 1973
- Keywords
- Admissibility of appeal (yes)
Admission of new main and auxiliary request (yes)
Main request: added subject-matter (no); extension of scope (no); novelty (yes) - Catchword
- See points 1 to 1.6
- Cited cases
- -
ORDER
For these reasons it is decided that:
1. The appeal is admissible.
2. Claims 1 to 6 of the main request filed with letter dated 18 September 2007 comply with the requirements of Articles 123(2) and (3), 84 and 54 EPC.
3. The debate with respect to the issue of inventive step of the main request is closed.
4. The procedure is continued in writing.